Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Venneos

Venneos?uq=K9LEA9hy
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
6 INVESTORS
Description

Developer of a silicon-chip-based imaging system designed to analyse biological cells. The company's silicon-chip-based imaging system helps in the label-free analysis of biological cells and to detect cellular changes which remain invisible with other technologies, providing researchers with information in areas such as tumor biology, immunology and pharmacology as well as in pharma and biotech companies.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Nobelstraße 15
  • 70569 Stuttgart
  • Germany

+49 0711 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Venneos’s full profile, request a free trial.

Venneos Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 26-Sep-2017 00.000 Completed Generating Revenue
2. Seed Round 11-Sep-2015 00.000 00.000 Completed Startup
1. Grant 13-Jul-2015 $2.2K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Venneos Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Born2Grow Venture Capital Minority 000 0000 000000 0
Business Angels Stuttgart Region Angel Group Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
Max Planck Innovation Corporation Minority 000 0000 000000 0
Venneos Beteiligungs Other Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Venneos Executive Team (4)

Name Title Board
Seat
Contact
Info
David Wehner Co-Founder & Managing Director
Ralf Zeitler Co-Founder & Managing Director
Jonas Lehmann Co-Founder
Tu Hoang Ph.D Co-Founder